Live session now available to view.
On pulmonary hypertension and COVID-19
Impact Factor of 2.205
A year in review
Through worldwide collaboration, we can begin to answer the question of a global disease.
Our members range from post-doctoral students, to the world’s leading cardiologists, pharmacologists and physicians.
Editor in Cheif of Pulmonary Circulation and Professor at University of California San Diego
We enable our members to collaborate through our bi-annual conferences.
Our Task Forces throughout the world combat the disease first hand in over 60 countries and specialise in 8 forms of PVD.
All in one place.